Towa Pharmaceutical Co., Ltd.

65
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3623150004
JPY
3,475.00
60 (1.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
2,59,594.00
2,27,934.00
2,08,859.00
1,65,615.00
1,54,900.00
1,10,384.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,59,594.00
2,27,934.00
2,08,859.00
1,65,615.00
1,54,900.00
1,10,384.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
1,627.00
947.00
1,127.00
230.00
190.00
131.00
General and Administration Expenses
71,486.00
50,493.00
51,934.00
40,162.00
34,881.00
25,909.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,36,351.00
2,10,286.00
2,03,344.00
1,47,079.00
1,34,971.00
94,213.00
Operating Profit (PBDIT) excl Other Income
23,243.00
17,648.00
5,515.00
18,536.00
19,929.00
16,171.00
Other Income
3,504.00
2,449.00
2,559.00
1,632.00
1,423.00
1,269.00
Operating Profit (PBDIT)
46,846.00
37,985.00
27,483.00
31,122.00
31,777.00
25,725.00
Interest
1,627.00
947.00
1,127.00
230.00
190.00
131.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
20,099.00
17,888.00
19,409.00
10,954.00
10,425.00
8,285.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
26,330.00
24,459.00
4,605.00
22,246.00
18,728.00
20,709.00
Provision for Tax
7,343.00
8,286.00
2,404.00
6,331.00
4,770.00
6,206.00
Profit After Tax
18,986.00
16,173.00
2,201.00
15,914.00
13,958.00
14,503.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
385.70
328.58
43.72
316.19
271.93
272.61
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 13.89% vs 9.13% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 31.70% vs 220.00% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 71.81% vs -15.97% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 17.39% vs 634.80% in Mar 2024

Compare Profit and Loss Results of Towa Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
2,59,594.00
94,035.00
1,65,559.00
176.06%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,59,594.00
94,035.00
1,65,559.00
176.06%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
1,627.00
28.00
1,599.00
5,710.71%
General and Administration Expenses
71,486.00
18,501.00
52,985.00
286.39%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,36,351.00
72,999.00
1,63,352.00
223.77%
Operating Profit (PBDIT) excl Other Income
23,243.00
21,036.00
2,207.00
10.49%
Other Income
3,504.00
455.00
3,049.00
670.11%
Operating Profit (PBDIT)
46,846.00
24,045.00
22,801.00
94.83%
Interest
1,627.00
28.00
1,599.00
5,710.71%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
20,099.00
2,554.00
17,545.00
686.96%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
26,330.00
19,435.00
6,895.00
35.48%
Provision for Tax
7,343.00
5,490.00
1,853.00
33.75%
Profit After Tax
18,986.00
13,945.00
5,041.00
36.15%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
385.6987
365.4153
20.28
5.55%
Profit And Loss - Net Sales
Net Sales 2,59,594.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 13.89% vs 9.13% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23,243.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 31.70% vs 220.00% in Mar 2024

Profit And Loss - Interest
Interest 1,627.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 71.81% vs -15.97% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 18,986.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 17.39% vs 634.80% in Mar 2024